Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?
GnRH agonist
anti-estrogen
aromatase inhibitors
gynecological cancers
hormonal therapy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
01 Feb 2022
01 Feb 2022
Historique:
received:
30
11
2021
revised:
27
01
2022
accepted:
30
01
2022
entrez:
15
2
2022
pubmed:
16
2
2022
medline:
16
2
2022
Statut:
epublish
Résumé
In recent years, hormone therapy has been shown to be a remarkable treatment option for cancer. Hormone treatment for gynecological cancers involves the use of medications that reduce the level of hormones or inhibit their biological activity, thereby stopping or slowing cancer growth. Hormone treatment works by preventing hormones from causing cancer cells to multiply. Aromatase inhibitors, anti-estrogens, progestin, estrogen receptor (ER) antagonists, GnRH agonists, and progestogen are effectively used as therapeutics for vulvar cancer, cervical cancer, vaginal cancer, uterine cancer, and ovarian cancer. Hormone replacement therapy has a high success rate. In particular, progestogen and estrogen replacement are associated with a decreased incidence of gynecological cancers in women infected with human papillomavirus (HPV). The activation of estrogen via the transcriptional functionality of ERα may either be promoted or decreased by gene products of HPV. Hormonal treatment is frequently administered to patients with hormone-sensitive recurring or metastatic gynecologic malignancies, although response rates and therapeutic outcomes are inconsistent. Therefore, this review outlines the use of hormonal therapy for gynecological cancers and identifies the current knowledge gaps.
Identifiants
pubmed: 35159024
pii: cancers14030759
doi: 10.3390/cancers14030759
pmc: PMC8833573
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Semin Reprod Med. 2010 Jan;28(1):81-90
pubmed: 20104432
Asian Pac J Cancer Prev. 2020 May 01;21(5):1445-1451
pubmed: 32458654
Cancers (Basel). 2020 Jun 22;12(6):
pubmed: 32580290
Breast Cancer Res Treat. 1999 Dec;58(3):205-11
pubmed: 10718482
J Clin Pathol. 2011 Jul;64(7):553-60
pubmed: 21330315
Lancet. 2007 Nov 10;370(9599):1609-21
pubmed: 17993361
Am J Pathol. 2013 Nov;183(5):1679-1687
pubmed: 24012679
BMC Cancer. 2013 Oct 29;13:506
pubmed: 24165149
Cancer Imaging. 2013 Mar 26;13:113-22
pubmed: 23545091
Gynecol Oncol. 2017 Dec;147(3):597-600
pubmed: 28923411
Int J Gynaecol Obstet. 2006 Feb;92(2):137-8
pubmed: 16256998
Climacteric. 2005 Dec;8(4):317-26
pubmed: 16390766
Ann Oncol. 2020 Feb;31(2):213-227
pubmed: 31959338
Rev Recent Clin Trials. 2015;10(4):289-97
pubmed: 26411952
Gynecol Oncol. 2010 Mar;116(3):424-9
pubmed: 19932916
Int J Gynecol Cancer. 2020 Jun;30(6):873-878
pubmed: 32241876
Pathol Oncol Res. 2020 Jan;26(1):63-78
pubmed: 30617760
Gynecol Endocrinol. 2017 Dec;33(12):946-950
pubmed: 28562130
Cancer Treat Rev. 2015 Dec;41(10):844-52
pubmed: 26476574
Ann Oncol. 2011 Sep;22 Suppl 6:vi35-9
pubmed: 21908501
Climacteric. 2010 Apr;13(2):132-40
pubmed: 19863455
Hum Reprod. 1997 Aug;12(8):1649-53
pubmed: 9308787
Br J Cancer. 2004 Jan 12;90(1):146-52
pubmed: 14710222
Climacteric. 2021 Apr;24(2):120-127
pubmed: 33236658
Cochrane Database Syst Rev. 2001;(1):CD001034
pubmed: 11279703
Cancer. 2015 Jul 1;121(13):2147-55
pubmed: 25757699
Gynecol Oncol. 1993 May;49(2):266-7
pubmed: 8504999
J Natl Cancer Inst. 1999 Jul 7;91(13):1131-7
pubmed: 10393721
Am J Obstet Gynecol. 1972 May 1;113(1):83-7
pubmed: 5025001
Int J Gynecol Cancer. 2004 Sep-Oct;14(5):871-4
pubmed: 15361197
Cancer. 1984 Sep 1;54(5):869-75
pubmed: 6537153
Int J Gynecol Cancer. 2007 Sep-Oct;17(5):964-78
pubmed: 17442022
Steroids. 2013 Jun;78(6):530-7
pubmed: 23402742
Crit Rev Food Sci Nutr. 2020 Dec 12;:1-18
pubmed: 33307763
Cancer. 2002 Apr 15;94(8):2192-8
pubmed: 12001117
Expert Rev Anticancer Ther. 2012 Jul;12(7):885-94
pubmed: 22845404
Gynecol Oncol. 2004 Aug;94(2):567-71
pubmed: 15297205
Clin Cancer Res. 2002 Jul;8(7):2233-9
pubmed: 12114425
J Clin Oncol. 2005 Feb 10;23(5):1011-27
pubmed: 15585754
Obstet Gynecol. 2010 Oct;116(4):876-883
pubmed: 20859151
Int J Cancer. 2021 Apr 5;:
pubmed: 33818778
Expert Rev Anticancer Ther. 2017 Jul;17(7):615-624
pubmed: 28608762
Clin Adv Hematol Oncol. 2005 Sep;3(9):723-36
pubmed: 16224447
Br J Dermatol. 1999 Sep;141(3):579-80
pubmed: 10583078
N Engl J Med. 2008 Mar 13;358(11):1160-74
pubmed: 18337605
Menopause. 2010 Mar;17(2):281-9
pubmed: 19779382
Gynecol Oncol. 1987 Feb;26(2):169-77
pubmed: 2433195
Antibiotics (Basel). 2021 Jul 06;10(7):
pubmed: 34356743
BMJ. 1997 Jul 12;315(7100):85-8
pubmed: 9240046
Trends Endocrinol Metab. 2015 Aug;26(8):399-401
pubmed: 26163756
Menopause. 2013 Jun;20(6):623-30
pubmed: 23361170
Int J Cancer. 2005 Mar 1;113(6):1005-9
pubmed: 15515017
Am J Obstet Gynecol. 1990 Apr;162(4):1099-103
pubmed: 2158235
Int J Gynecol Cancer. 2012 Jul;22(6):1006-12
pubmed: 22740004
Am Soc Clin Oncol Educ Book. 2016;35:e40-54
pubmed: 27249746
Cancer Res. 2013 Aug 15;73(16):5016-28
pubmed: 23824740
Mod Pathol. 2010 Mar;23(3):404-12
pubmed: 20062014
Int J Oncol. 2012 Jun;40(6):1755-62
pubmed: 22366992
Gynecol Oncol. 2017 Jul;146(1):64-68
pubmed: 28461031
Gynecol Oncol. 2004 Oct;95(1):133-8
pubmed: 15385122
Am J Surg Pathol. 2010 Mar;34(3):433-43
pubmed: 20154587
J Natl Cancer Inst. 1997 Aug 6;89(15):1110-6
pubmed: 9262248
Cancer Biol Ther. 2011 Feb 1;11(3):295-306
pubmed: 21239888
Clin Breast Cancer. 2022 Jan;22(1):e48-e58
pubmed: 34429242
J Reprod Med. 1994 Nov;39(11):857-61
pubmed: 7853273
J Womens Health (Larchmt). 2016 May;25(5):431-42
pubmed: 27058301
Arch Intern Med. 2000 Mar 27;160(6):809-15
pubmed: 10737280
Menopause. 2021 May 28;28(9):998-1003
pubmed: 34054104
PLoS One. 2016 Jan 25;11(1):e0147029
pubmed: 26808155
Gynecol Oncol. 2006 Jun;101(3):464-9
pubmed: 16368128
Cytopathology. 2012 Feb;23(1):6-12
pubmed: 22243288
Am J Epidemiol. 2003 May 15;157(10):923-9
pubmed: 12746245
Med Electron Microsc. 2003 Mar;36(1):9-17
pubmed: 12658347
Am J Obstet Gynecol. 2008 Sep;199(3):e7-e10
pubmed: 18550023
Lancet Oncol. 2006 Nov;7(11):910-8
pubmed: 17081916
Eur J Cancer. 1994;30A(5):697-8
pubmed: 8080689
Nat Commun. 2014 Oct 03;5:5092
pubmed: 25277212
Obstet Gynecol Sci. 2017 Sep;60(5):481-484
pubmed: 28989927
Maturitas. 2010 May;66(1):23-6
pubmed: 20303222
Ann Intern Med. 1978 Jan;88(1):69-77
pubmed: 339802
Maturitas. 2011 Jan;68(1):94-7
pubmed: 21156341
Endocr Relat Cancer. 2009 Jun;16(2):363-80
pubmed: 19190080
Gynecol Oncol. 1996 Nov;63(2):204-9
pubmed: 8910628
Am J Physiol Cell Physiol. 2015 Oct 1;309(7):C444-56
pubmed: 26224579
Oncol Lett. 2015 Nov;10(5):3310-3314
pubmed: 26722331
Molecules. 2021 Dec 04;26(23):
pubmed: 34885950
Drug Discov Today. 2014 Sep;19(9):1498-502
pubmed: 25058385
J Cancer Res Clin Oncol. 2020 Jun;146(6):1567-1573
pubmed: 32189105
J Cell Sci. 2014 Jun 15;127(Pt 12):2621-6
pubmed: 24741068
Mol Cell Endocrinol. 2010 Nov 25;329(1-2):47-55
pubmed: 20444430
J Steroid Biochem Mol Biol. 2014 Jul;142:52-61
pubmed: 23871991
Gynecol Oncol. 2011 Aug;122(2):447-54
pubmed: 21474167
Arch Intern Med. 1999 May 24;159(10):1061-6
pubmed: 10335682
Int J Gynecol Cancer. 2007 Mar-Apr;17(2):325-38
pubmed: 17362310
Cancer Res. 2000 Nov 15;60(22):6281-7
pubmed: 11103784
Future Oncol. 2009 Dec;5(10):1641-57
pubmed: 20001801
Cells. 2021 Feb 01;10(2):
pubmed: 33535622
Clin Colorectal Cancer. 2018 Jun;17(2):e281-e288
pubmed: 29398422
Int J Clin Oncol. 2012 Aug;17(4):348-54
pubmed: 21830086
Int J Womens Health. 2013;5:133-9
pubmed: 23526171
Gynecol Oncol. 2003 Jul;90(1):170-6
pubmed: 12821359
Cancer. 1953 Sep;6(5):963-8
pubmed: 13094644
Clin Exp Metastasis. 2009;26(4):273-87
pubmed: 18498004
Am Fam Physician. 2000 Mar 1;61(5):1369-76
pubmed: 10735343
Menopause. 2010 May-Jun;17(3):480-6
pubmed: 20032798
Mod Pathol. 2005 Apr;18(4):573-6
pubmed: 15529183
Med Oncol. 2003;20(1):87-93
pubmed: 12665689
Taiwan J Obstet Gynecol. 2007 Mar;46(1):26-32
pubmed: 17389185
Climacteric. 2013 Dec;16(6):611-7
pubmed: 23952524
Curr Med Res Opin. 2015 Jan;31(1):1-12
pubmed: 25365466
Cancer Res. 2008 Aug 1;68(15):6331-40
pubmed: 18676858
Int J Cancer. 1987 Aug 15;40(2):198-201
pubmed: 3038757
Int J Gynecol Pathol. 2006 Jan;25(1):22-9
pubmed: 16306780
Ann Intern Med. 2000 Dec 19;133(12):942-50
pubmed: 11119395
J Natl Cancer Inst. 2011 Feb 16;103(4):296-305
pubmed: 21278356
J Chemother. 2013 Apr;25(2):96-103
pubmed: 23684357
Gynecol Oncol. 2003 Sep;90(3):547-51
pubmed: 13678722
Oncology. 2004;66(2):112-7
pubmed: 15138362
Cancer Med. 2019 Apr;8(4):1339-1349
pubmed: 30897294
Gynecol Oncol. 1988 Jun;30(2):228-38
pubmed: 3371749
Menopause. 2015 Jun;22(6):633-9
pubmed: 25405572
Eur J Obstet Gynecol Reprod Biol. 2009 May;144(1):80-4
pubmed: 19269732
Br J Cancer. 2007 Jan 15;96(1):151-6
pubmed: 17179984
Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19467-72
pubmed: 19901334
Int J Cancer. 2002 Oct 20;101(6):549-54
pubmed: 12237896
J Clin Oncol. 1989 Jan;7(1):115-8
pubmed: 2491882
Hum Pathol. 2014 May;45(5):917-25
pubmed: 24746196
Ann Oncol. 2013 Oct;24 Suppl 6:vi33-8
pubmed: 24078661
J Virol. 1989 Aug;63(8):3261-9
pubmed: 2545902
J Clin Pathol. 2012 Feb;65(2):133-9
pubmed: 22128196
Cancers (Basel). 2021 Jun 01;13(11):
pubmed: 34205890
J Clin Endocrinol Metab. 1987 Jul;65(1):164-9
pubmed: 2953750
Gynecol Oncol. 2005 May;97(2):652-5
pubmed: 15863173
Climacteric. 2020 Aug;23(4):343-349
pubmed: 32233689
Cancers (Basel). 2020 Dec 11;12(12):
pubmed: 33322519
Int J Gynecol Pathol. 2008 Apr;27(2):151-60
pubmed: 18317228
Int J Cancer. 1991 Jun 19;48(4):533-9
pubmed: 1646176
Am J Pathol. 2010 Sep;177(3):1053-64
pubmed: 20651229
Gynecol Oncol. 1997 Mar;64(3):496-500
pubmed: 9062159
Gynecol Oncol. 2016 Dec;143(3):584-588
pubmed: 27751589
Anticancer Res. 2016 Oct;36(10):5031-5042
pubmed: 27798862
Trends Endocrinol Metab. 2010 Aug;21(8):504-11
pubmed: 20456973
Expert Rev Anticancer Ther. 2006 Jan;6(1):33-42
pubmed: 16375642
Gynecol Endocrinol. 2007 Jan;23(1):25-8
pubmed: 17484508
Anticancer Res. 1993 Nov-Dec;13(6B):2457-63
pubmed: 7907850